Skip to main content
. 2020 Dec 22;13(1):3. doi: 10.3390/cancers13010003

Figure 5.

Figure 5

Nomograms to predict disease-free survival in patients with CRC. Nomograms were performed by using clinicopathological characteristics and DFS-PII to predict disease-free survival (A) and calibration curves of the nomogram to predict disease-free survival at 3 years in the training cohort (B) and the validation cohort (C). Nomograms map the predicted probabilities onto points on a scale from 0 to 100 and can be interpreted by accumulating the points that correspond to the predicted probability, which is indicated at the top of scale. The total points were converted to predict 1-, 3- and 5-year probabilities of death and recurrence or metastasis for patients with CRC.